• Product NamePramiracetam
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityPramiracetam is a more potent nootropic drug derived from piracetam. Pramiracetam reportedly improved cognitive deficits associated with traumatic brain injuries. Pramiracetam was also effective in the treatment of cognitive disorders of cerebrovascular and traumatic origins.
• Target NameOthers
• CAS No. 68497-62-1
• Calculated MW 269.38
• Formulation C14H27N3O2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C
  Pathways:Others
  Receptor:Others
  Boling pt:461C?
  Melting pt:
  Solubility:DMSO: 54 mg/mL (200.46 mM)
  Appearance:White Crystal
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Corasaniti MT, et al. Funct Neurol. 1995 May-Jun;10(3):151-5.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting